Intabio Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Investors
-
2
Intabio General Information
Description
Developer of a real-time protein analytics platform intended to transform and accelerate the development of biotherapeutic drugs. The company's platform provides early product quality characterization and profound efficiency gains across all stages of biopharmaceutical development and manufacturing, enabling bio-therapeutic drug manufacturers to conduct a comprehensive analysis of antibody and protein bio-pharmaceutical in development, offering significant throughput over traditional methods at a fraction of the cost.
Contact Information
Website
www.intabio.comCorporate Office
- 47370 Fremont Boulevard
- Fremont, CA 94539
- United States
Corporate Office
- 47370 Fremont Boulevard
- Fremont, CA 94539
- United States
Intabio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 21-Jan-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 01-Dec-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Apr-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 30-Oct-2018 | Completed | Generating Revenue | |||
| 3. Grant | 15-Aug-2018 | Completed | Generating Revenue | |||
| 2. Grant | 10-Aug-2018 | $2.32M | $3.2M | Completed | Generating Revenue | |
| 1. Seed Round | 14-Sep-2017 | $3.2M | $3.2M | Completed | Generating Revenue |
Intabio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed | 15,743,383 | $0.000100 | 8% | $0.2 | $0.2 | 1x | $0.2 | 13.14% |
Intabio Comparisons
Industry
Financing
Details
Intabio Competitors (4)
One of Intabio’s 4 competitors is Codexis, a Formerly VC-backed company based in Redwood City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Codexis | Formerly VC-backed | Redwood City, CA | ||||
| Avenir Wellness Solutions | Formerly VC-backed | Oxnard, CA | ||||
| Roxlor | Corporation | Wilmington, DE | ||||
| 908 Devices | Formerly VC-backed | Burlington, MA |
Intabio Signals
Intabio Former Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agility Labs | Accelerator/Incubator | Minority | ||
| Angel (individual) | Minority | |||
| CSC UpShot Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Intabio FAQs
-
When was Intabio founded?
Intabio was founded in 2015.
-
Where is Intabio headquartered?
Intabio is headquartered in Fremont, CA.
-
What is the size of Intabio?
Intabio has 20 total employees.
-
What industry is Intabio in?
Intabio’s primary industry is Discovery Tools (Healthcare).
-
Is Intabio a private or public company?
Intabio is a Private company.
-
What is Intabio’s current revenue?
The current revenue for Intabio is .
-
How much funding has Intabio raised over time?
Intabio has raised $30.7M.
-
Who are Intabio’s investors?
Agility Labs, , CSC UpShot Ventures, , and are 5 of 27 investors who have invested in Intabio.
-
Who are Intabio’s competitors?
Codexis, Avenir Wellness Solutions, Roxlor, and 908 Devices are competitors of Intabio.
-
When was Intabio acquired?
Intabio was acquired on 21-Jan-2021.
-
Who acquired Intabio?
Intabio was acquired by SCIEX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process